John P Dubinsky's Net Worth
$3.78 Million
Who is John P Dubinsky?
John P Dubinsky has an estimated net worth of $3.78 Million. This is based on reported shares across multiple companies, which include Aegion Corp, STIFEL FINANCIAL CORP, and ACCENTIA BIOPHARMACEUTICALS INC.
SEC CIK
John P Dubinsky's CIK is 0001181348
Past Insider Trading and Trends
2004 was John P Dubinsky's most active year for acquiring shares with 11 total transactions. John P Dubinsky's most active month to acquire stocks was the month of December. 2010 was John P Dubinsky's most active year for disposing of shares, totalling 9 transactions. John P Dubinsky's most active month to dispose stocks was the month of November. 2013 saw John P Dubinsky paying a total of $180,600.00 for 15,667 shares, this is the most they've acquired in one year. In 2020 John P Dubinsky cashed out on 35,325 shares for a total of $1,021,726.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aegion Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.33% | -5.00K |
$22.30 | -$111,500.00 | 15.55K |
Aug 26
| |||
Form 4
| +20.90% | 4.57K |
—
|
—
| 26.42K |
May 14
| |||
Form 4
| -19.57% | -5.00K |
$20.90 | -$104,518.34 | 20.55K |
Dec 11
| |||
Form 4
| +25.56% | 4.78K |
—
|
—
| 23.48K |
May 9
| |||
Form 4
| +8.42% | 3.31K |
—
|
—
| 42.63K |
Apr 20
| |||
Form 4
| +9.03% | 3.26K |
—
|
—
| 39.31K |
Apr 21
| |||
Form 4
| +16.97% | 5.23K |
—
|
—
| 36.06K |
Apr 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
| +6,578.95% | 10K |
$22.15 | $221,510.60 | 10.15K |
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
| No matching records found | |||||||||
STIFEL FINANCIAL CORP (SF) Snapshot price: $74.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.85% | -2.40K |
$51.55 | -$123,720.00 | 16.28K |
Jun 3
| |||
Form 4
| -27.26% | -7.00K |
$46.98 | -$328,880.00 | 18.68K |
May 21 - May 26
| |||
Form 4
| +57.74% | 9.4K |
—
|
—
| 25.68K |
May 15
| |||
Form 4
| -43.97% | -12.78K |
$44.55 | -$569,126.25 | 16.28K |
May 8
| |||
Form 4
| +14.82% | 3.75K |
—
|
—
| 29.06K |
Jan 2
| |||
Form 4
| -7.83% | -2.15K |
$56.79 | -$122,098.50 | 25.31K |
Sep 10
| |||
Form 4
| -5.18% | -1.50K |
$54.71 | -$82,065.00 | 27.46K |
Sep 5
| |||
Form 4
| -6.46% | -2.00K |
$57.25 | -$114,500.00 | 28.96K |
Jun 19
| |||
Form 4
| +6.54% | 1.9K |
—
|
—
| 30.96K |
Jun 5 - Jun 6
| |||
Form 4
| +13.25% | 3.75K |
—
|
—
| 32.06K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
| +7.20% | 1.9K |
—
|
—
| 28.31K |
Jun 6 - Jun 7
| |||
Form 4
| +16.55% | 3.75K |
—
|
—
| 26.41K |
Dec 29
| |||
Form 4
| -16.68% | -4.54K |
—
|
—
| 22.66K |
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4/A
| -15.27% | -4.00K |
$45.15 | -$180,600.00 | 22.19K |
Nov 21
| |||
Form 4
| +14.17% | 3.38K |
—
|
—
| 27.19K |
Dec 30
| |||
Form 4
| -17.35% | -5.00K |
$50.20 | -$251,000.00 | 23.82K |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +10.09% | 3.38K |
—
|
—
| 36.82K |
Jan 22
| |||
Form 4
|
—
|
0
|
$29.50 | -$11,250.00 | 33.44K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -4.29% | -1.50K |
$55.89 | -$83,835.00 | 33.44K |
Mar 12
| |||
Form 4
| +10.69% | 3.38K |
—
|
—
| 34.94K |
Jan 22
| |||
Form 4
| -5.96% | -2.00K |
$49.95 | -$99,900.00 | 31.57K |
Dec 3 - Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +11.18% | 3.38K |
—
|
—
| 33.57K |
Jan 24
| |||
Form 4
| +15.27% | 4K |
$45.15 | $180,600.00 | 30.19K |
Nov 21
| |||
Form 4
| -10.28% | -3.00K |
$40.00 | -$120,000.00 | 26.19K |
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +12.96% | 3.35K |
—
|
—
| 29.19K |
Jan 24
| |||
Form 4
| +16.80% | 3.72K |
—
|
—
| 25.84K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +24.75% | 2.93K |
—
|
—
| 14.75K |
Jan 19
| |||
Form 4
|
—
|
0
|
$35.73 | -$197,149.55 | 11.82K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
| +55.60% | 4.22K |
—
|
—
| 11.82K |
Jan 20
| |||
Form 4
|
—
|
0
|
$30.53 | -$469,490.00 | 7.6K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCENTIA BIOPHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| +0.74% | 1.05K |
$8.00 | $8,400.00 | 143.39K |
Apr 3
| |||
Form 4
| -40.07% | -95.16K |
—
|
—
| 142.34K |
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||